Live Cell Imaging Market: Growing Availability of Research Funds
Posted by Kriti on June 1st, 2021
The research study involves four major activities in estimating the size of the live cell imaging market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through primary research. The bottom-up approach was employed to estimate the overall market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=163914483
Major Market Growth Drivers:
Revenue Growth Analysis:
Based on product & service, the global live cell imaging market is segmented into instruments, consumables, software, and services. The consumables segment, on the other hand, is expected to grow at the highest CAGR during the forecast period. The need for the frequent purchase of consumables is expected to play a key role in the growth of the consumables market during the forecast period.
The pharmaceutical & biotechnology companies segment accounted for the largest share of the live cell imaging market in the year 2019.
Based on end user, the live cell imaging market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and contract research organizations (CROs). In 2019, pharmaceutical & biotechnology companies segment accounted for the largest share of the live cell imaging market. The large share of this segment can be attributed to the increasing R&D activities and the patent cliff of various blockbuster drugs.
The Asia Pacific region is expected to show the highest growth rate during the forecast period.
Geographically, the global Live cell imaging instruments market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific is expected to show the highest growth rate during the forecast period. The high growth rate of this region can mainly be attributed to the factors such as the government initiatives for research on stem cell therapy, the rising prominence of regenerative medicine research, growth of preclinical/clinical research in China, favorable changes in foreign direct investment (FDI) regulations in the pharmaceutical industry in India, and growth of the pharmaceutical and biopharmaceutical sectors in South Korea.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Key Live Cell Imaging Instruments Market Players:
Like it? Share it!
About the AuthorKriti
Joined: July 3rd, 2019
Articles Posted: 390
More by this author